Clinical Trial Update: Comparison of C-Reactive Protein Levels in Traumatic Brain Injury Patients Undergoing Craniotomy With and Without Dexmedetomidine [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing C-reactive protein levels in traumatic brain injury patients undergoing craniotomy with versus without dexmedetomidine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: Universitas Jenderal Soedirman | Conditions: Traumatic Brain Injury | Phase 4 | Status: COMPLETED